Report in English with a Dutch summary (KCE reports 45A)

More documents

Recommendations

Info

234 Screening for Colorectal Cancer KCE reports vol.45 314. Rostom A, Jolicoeur E, Dube C, Gregoire S, Patel D, Saloojee N, et al. A randomized prospective trial comparing different regimens of oral sodium phosphate and polyethylene glycol-based lavage solution in the preparation of patients for colonoscopy. Gastrointest Endosc. 2006;64(4):544-52. 315. SFED. http://www.sfed.org/. 316. Haseman JH, Lemmel GT, Rahmani EY, Rex DK. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc. 1997;45(6):451-5. 317. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10year interval between colonoscopies. JAMA. 2006;295(20):2366-73. 318. Brenner H, Chang-Claude J, Seiler CM, Sturmer T, Hoffmeister M. Does a negative screening colonoscopy ever need to be repeated? Gut. 2006;55(8):1145-50. 319. Kwok H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis. 2000;15(1):9-20. 320. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349(23):2191-200. 321. Pickhardt PJ. Differential diagnosis of polypoid lesions seen at CT colonography (virtual colonoscopy). Radiographics. 2004;24(6):1535-56; discussion 57-9. 322. Pickhardt PJ, Nugent PA, Choi JR, Schindler WR. Flat colorectal lesions in asymptomatic adults: implications for screening with CT virtual colonoscopy. AJR Am J Roentgenol. 2004;183(5):1343-7. 323. Pickhardt PJ. CT colonography (virtual colonoscopy) for primary colorectal screening: challenges facing clinical implementation. Abdom Imaging. 2005;30(1):1-4. 324. Rex DK. CT and MR colography (virtual colonoscopy): status report. J Clin Gastroenterol. 1998;27(3):199-203. 325. Pappalardo G, Polettini E, Frattaroli FM, Casciani E, D'Orta C, D'Amato M, et al. Magnetic resonance colonography versus conventional colonoscopy for the detection of colonic endoluminal lesions. Gastroenterology. 2000;119(2):300-4. 326. Schoenfelder D, Debatin JF. The role of MR colonography for colorectal cancer screening. Semin Roentgenol. 2000;35(4):394-403. 327. Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JRT. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Annals of Surgery. 2006;243(3):348-52. 328. ICSI. Computed Tomographic Colonography for Detection of Colorectal Polyps and Neoplasms. Technology Assessmant Reports. 2004;058(http://www.icsi.org/knowledge/detail.asp?catID=107&itemID=272). 329. Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA. 2004;291(14):1713-9. 330. Laghi A. Virtual colonoscopy: clinical application. European Radiology. 2005;15(4). 331. Eguchi S, Kohara N, Komuta K, Kanematsu T. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer. 1996;77(8 Suppl):1707-10. 332. Deuter R, Muller O. Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR. Human Mutation. 1998;11(1):84-9. 333. Lev Z, Kislitsin D, Rennert G, Lerner A. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer. Journal of Cellular Biochemistry Supplement. 2000;34:35-9. 334. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. Journal of the National Cancer Institute. 2001;93(11):858-65.
KCE reports vol.45 Screening for Colorectal Cancer 235 335. Doolittle BR, Emanuel J, Tuttle C, Costa J. Detection of the mutated K-Ras biomarker in colorectal carcinoma. Experimental & Molecular Pathology. 2001;70(3):289-301. 336. Berger BM, Vucson BM, Diteberg JS. Gene mutations in advanced colonic polyps: potential marker selection for stool-based mutated human DNA assays for colon cancer screening. Clinical Colorectal Cancer. 2003;3(3):180-5. 337. Boynton KA, Summerhayes IC, Ahlquist DA, Shuber AP. DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clinical Chemistry. 2003;49(7):1058-65. 338. Chu E. The role of stool DNA analysis in the early detection and screening of colorectal cancer. Clinical Colorectal Cancer. 2003;3(1):9. 339. Tagore KS, Lawson MJ, Yucaitis JA, Gage R, Orr T, Shuber AP, et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clinical Colorectal Cancer. 2003;3(1):47-53. 340. Calistri D, Rengucci C, Lattuneddu A, Francioni G, Polifemo AM, Nanni O, et al. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia (New York). 2004;6(5):536-40. 341. Spethmann S, Fischer C, Wagener C, Streichert T, Tschentscher P. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer. International Journal of Molecular Medicine. 2004;13(3):451-4. 342. Wu GH-M, Wang Y-M, Yen AM-F, Wong J-M, Lai H-C, Warwick J, et al. Costeffectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer. 2006;6(136). 343. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol. 2003;38(6):635-42. 344. Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control. 2005;16(7):865-75. 345. Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000;342(24):1766- 72. 346. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343(3):169-74. 347. Hardcastle J. Randomized control trial of faecal occult blood screening for colorectal cancer: results for the first 144,103 patients. Eur J Cancer Prev. 1991;1 Suppl 2(21):21. 348. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472-7. 349. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989;24(5):599-606. 350. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467-71. 351. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50(1):29-32.
Page 1 and 2:
Health Technology Assessment Colore
Page 3 and 4:
Health Technology Assessment Colore
Page 5 and 6:
KCE reports vol.45A Colorectale Kan
Page 7 and 8:
Page 9:
Page 12 and 13:
2 Screening for Colorectal Cancer K
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
10 Screening for Colorectal Cancer
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195: 184 Screening for Colorectal Cancer
Page 259 and 260: This page is left intentionally bla
Page 261: KCE reports 1. Effectiviteit en kos
show all

Report in English with a Dutch summary (KCE reports 45A)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?